Sage Journals: Discover world-class research

Retricted access

Review article

First published 2014-12

CRMP2

Jacque P.K. Ip, Amy K.Y. Fu, Nancy Y. Ip

The Neuroscientist

Retricted access

Research article

First published 2011-11-29

CRMP2 Hyperphosphorylation is Characteristic of Alzheimer's Disease and not a Feature Common to Other Neurodegenerative Diseases

Ritchie Williamson, Lidy van Aalten, David M.A. Mann [...]

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2019-10-29

aFGF Promotes Neurite Growth by Regulating GSK3β-CRMP2 Signaling Pathway in Cortical Neurons Damaged by Amyloid-β

Qin Cao, Tian Meng, Jianhui Man [...]

Journal of Alzheimer’s Disease

Open access

Review article

First published 2016-6-22

Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer’s Disease: Comparison and Contrast with Microtubule-Associated Protein Tau

Kenneth Hensley, Petri Kursula

Journal of Alzheimer’s Disease

Open access

Research article

First published 2019

Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis

Aubin Moutal, Sergey Kalinin, Kathy Kowal [...]

ASN Neuro

Retricted access

Research article

First published 2018-11

Increased Levels of Circulating Glial Fibrillary Acidic Protein and Collapsin Response Mediator Protein-2 Autoantibodies in the Acute Stage of Spinal Cord Injury Predict the Subsequent Development of Neuropathic Pain

Georgene W. Hergenroeder, John B. Redell, H. Alex Choi [...]

Journal of Neurotrauma

Open access

Research article

First published 2026-3

Deciphering the Intricacies of Breast Cancer Signaling Network and the Potential of Soy-derived Isoflavones on Cancer Therapeutics

Amir Mahgoub Awadelkareem, Abd Elmoneim O. Elkhalifa, Mohd Adnan [...]

Pharmacognosy Magazine

Search results

CRMP2

CRMP2 Hyperphosphorylation is Characteristic of Alzheimer's Disease and not a Feature Common to Other Neurodegenerative Diseases

aFGF Promotes Neurite Growth by Regulating GSK3β-CRMP2 Signaling Pathway in Cortical Neurons Damaged by Amyloid-β

Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer’s Disease: Comparison and Contrast with Microtubule-Associated Protein Tau

Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis

Increased Levels of Circulating Glial Fibrillary Acidic Protein and Collapsin Response Mediator Protein-2 Autoantibodies in the Acute Stage of Spinal Cord Injury Predict the Subsequent Development of Neuropathic Pain

Deciphering the Intricacies of Breast Cancer Signaling Network and the Potential of Soy-derived Isoflavones on Cancer Therapeutics